Rankings
▼
Calendar
STTK Q2 2024 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena
STTK
Shattuck Labs, Inc.
$291M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+704.5% YoY
Gross Profit
$647,000
40.2% margin
Operating Income
-$23M
-1427.1% margin
Net Income
-$22M
-1339.5% margin
EPS (Diluted)
$-0.42
QoQ Revenue Growth
+44.3%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$129M
Total Liabilities
$18M
Stockholders' Equity
$111M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$200,000
+704.5%
Gross Profit
$647,000
-$18M
+103.6%
Operating Income
-$23M
-$23M
-0.9%
Net Income
-$22M
-$21M
-1.0%
Revenue Segments
License
$2M
100%
← FY 2024
All Quarters
Q3 2024 →